"TX: primary tumour cannot be assessed"
"T0: no evidence of primary tumour"
"T1: a clinically inapparent tumour that is not palpable"
"T1a: tumour incidental histologic finding in 5% or less of tissue resected"
"T1b: tumour incidental histologic finding in more than 5% of tissue resected"
"T1c: tumour identified by needle biopsy found in one or both sides, but not palpable"
"T2: tumour is palpable and confined within the prostate"
"T2a: tumour involves one-half of one side or less"
"T2b: tumour involves more than one-half of one side but not both sides"
"T2c: tumour involves both sides"
"T3: an extraprostatic tumour that is not fixed or does not invade adjacent structures"
"T3a: extraprostatic extension (unilateral or bilateral)"
"T3b: tumour invades seminal vesicle(s)"
"T4: tumour is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall"
"T2: organ confined"
"T3: extraprostatic extension"
"T3a: extraprostatic extension (unilateral or bilateral) or microscopic invasion of the bladder neck"
"T3b: tumour invades seminal vesicle(s)"
"T4: tumour is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall"
"NX: regional nodes were not assessed"
"N0: no positive regional nodes"
"N1: metastases in regional node(s)"
"M0: no distant metastasis"
"M1: distant metastasis"
"M1a: non-regional lymph node(s)"
"M1b: bone(s)"
"M1c: other site(s) with or without bone disease"
"T3b: tumour invades seminal vesicle(s)"
"T3b: tumour invades seminal vesicle(s)"
"N1: metastases in regional node(s)"
"M1a: non-regional lymph node(s)"
"M1b: bone(s)"
"M1c: other site(s) with or without bone disease"
"Prostate cancer staging takes into account a TNM staging system (primary site, nodal and distant metastases), pretreatment PSA and histological grading. The Gleason score is used to determine the Grade Group."
"Prostate cancer staging takes into account a TNM staging system (primary site, nodal and distant metastases), pretreatment PSA and histological grading. The Gleason score is used to determine the Grade Group."
"Additionally, there is some overlap with prebiopsy imaging assessment using Prostate Imaging-Reporting and Data System (PI-RADS)."
"TNM staging"
"TX: primary tumour cannot be assessed"
"Nodal status is based on PSMA PET-CT, MRI or CT. On MRI/CT a 1 cm short-axis diameter cut-off is used if the size is the sole criterion for adenopathy 1."
"NX: regional nodes were not assessed"
"Prognostic stage groupings (table 1) are determined by TNM, pretreatment serum PSA and histologic Grade Groups 7."
"Prognostic stage groupings (table 1) are determined by TNM, pretreatment serum PSA and histologic Grade Groups 7."
"T1a: tumour incidental histologic finding in 5% or less of tissue resected"
"T1b: tumour incidental histologic finding in more than 5% of tissue resected"
"T1c: tumour identified by needle biopsy found in one or both sides, but not palpable"
"T2a: tumour involves one-half of one side or less"
"T2b: tumour involves more than one-half of one side but not both sides"
"T2c: tumour involves both sides"
"T3a: extraprostatic extension (unilateral or bilateral)"
"T3b: tumour invades seminal vesicle(s)"
"T3a: extraprostatic extension (unilateral or bilateral) or microscopic invasion of the bladder neck"
"T3b: tumour invades seminal vesicle(s)"
"M1a: non-regional lymph node(s)"
"M1b: bone(s)"
"M1c: other site(s) with or without bone disease"
"Regional nodal status (N)"
"Distant metastasis (M)"
Expected headings
"TNM staging"
"Clinical primary tumour staging (cT)"
"Pathological primary tumour staging (pT)"
"Regional nodal status (N)"
"Distant metastasis (M)"
"Histologic grading"
"Stage groupings"
"Prostate cancer staging takes into account a TNM staging system (primary site, nodal and distant metastases), pretreatment PSA and histological grading. The Gleason score is used to determine the Grade Group."
"Nodal status is based on PSMA PET-CT, MRI or CT. On MRI/CT a 1 cm short-axis diameter cut-off is used if the size is the sole criterion for adenopathy 1."